Werner Frosch is partner at Henning Larsen and managing director of Henning Larsen GmbH in Munich. He has vast experience of all project stages and expert knowledge of managing processes in relation to time, economy and architectural quality. He ensures a good and open dialogue on the projects and close collaboration between client and users. An important goal in his work is to achieve the highest possible architectural quality and value for clients and users based on program requirements, technical solutions, and other obligations. Henning Larsen is an international firm practicing comprehensive integrated design with the goal to create vibrant, sustainable buildings, masterplans, urban spaces, interior design, and graphics. Our broad portfolio includes flagship commercial headquarters, state-of-the-art universities and research institutes, cultural landmarks, and sustainable city districts. Our approach to design is rooted in a Scandinavian ethos and goes beyond the physical and visual impact of a project.
We are a free community of architects an engineers with our office in Munich.
Our field of activity includes the construction of new buildings as well as renovation and remodelling of historic buildings, primarily for privet clients and investors.
In addition to the planning of office and residential buildings as well as private houses, the focus is on the design and realization of the hotels of the high and highest standard.
Among other things, our office is characterized by the international nature of the projects. As a result, our experience in international project partnerships have been recently extended particularly intensively to the eastern EU countries.
The commonality of the architectural designs lies in their variety and diversity. The architectural form does not evolve from recurrent themes; rather, it is to develop from the respective task and the specific location, always in a new and unmistakable manner, to a conceptual coherence.
This attitude has been recognized in several international architecture awards and successful international competitions.
We take part on the different architectural congresses and the lectures for students at the Universities.
An architect, educator, researcher, writer, maker, and Director of the Bartlett School of Architecture. Co-Founded sixteen*(makers) in 1992. Editor of 6 books, and author of multiple chapters and papers. Designer and maker of multiple projects, including 55/02 at Kielder Park (2007). Co-Founder of the International triennal conference and book FABRICATE, running since 2011 from London to Zurich to Stuttgart. Academic on the €4.5m EU Funded Innochain Network, in collaboration with 4 other EU institutions, over 20 Industry Partners, and 15 Research Fellows, due for completion in March 2019.
Tateo Nakajima is a Director of Arup, an international firm of designers, planners and consultants working across all aspects of the built environment.
Building on formal training and early career in violin performance and conducting, Tateo is an internationally recognized leader in the design and planning of cultural venues and developments. He has lead projects around the world, working with many of the highest profile architecture and design practices, and with some of the most influential artists and music ensembles today. He has had overall design and management responsibility for projects ranging from concert halls and opera houses to pop entertainment venues, museums, immersive experiences, and arts, culture & entertainment districts.
Prior to joining Arup, Tateo was a Partner and Principal Designer with Artec Consultants Inc, working on the venue/theatre planning and auditorium acoustics aspects of acclaimed projects worldwide.
Ciara Gormley is a competition and award winning, design focused Architect, who has been a Partner at PDP London for the last 12 years.
With over 20 years of professional practice, working in both the UK, Ireland and Europe Ciara’s recent portfolio includes complex and award winning sustainable masterplans, strategic design frameworks, High quality new build schemes, in difficult urban environments, and sensitive rural designs.
Ciara’s interest is in the whole process from inception to the delivery onsite, and she focus is to retain the vision at all stages whilst delivering the clients objectives and managing large teams and complex legislative landscapes.
Vanessa is the MD of Clinical Services International (CSI) a leading provider of Clinical Trial Supplies to the Biopharmaceutical Industry. Vanessa started her career as a research associate at Scotland Yard. Subsequently she worked for leading CROs and with some of the largest biopharmaceutical and Biotechscompanies to provide innovative solutions. She has extensive experience in drug development from Preclinical to registration and commercialization strategies and has secured product registration for several orphans and first in class drugs. She has a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge and Masters in Market Access from University m University of Lyon.
After 25+ years’ experience in the digitalization of clinical trials, the active participation of Benoît in the public-private consortium EHR4CR (Electronic Health Record for Clinical Research) has made him realize that there is a lot of value in all the data collected in the routine clinical setting and we should really maximize such usage in the best interest of medical research and thus the patients. Nevertheless, that is only achievable if we involve the patients in the most trustable, transparent and privacy respectful way. Through his participation to Partners for Patients, Benoît ambitions to promote the various approaches going in such a direction.
Anne Reid is the Program Director of the Office of Medical Device and Radiological Health Operations (OMDRHO). OMDRHO is one of five programs in the Office of Medical Products Operations within FDA’s Office of Regulatory Affairs. She is a career FDA federal service veteran with vast experience in technical and managerial positions across multiple commodities. Anne came to FDA in 1990 with an undergraduate degree in Biochemistry and a master’s degree in Food Science and segued into FDA’s laboratory science regulatory operations. Since 2000, Anne has held supervisory and branch director positions. In 2010 she became the Deputy Director of ORA’s Southeast Region, and in 2012 she assumed the responsibilities of Acting Director for the Southeast Region. Collaterally with her Regional Food and Drug Director duties, Anne served as the acting program director for both the Biologics and Tobacco programs during significant planning phases for program alignment. She became the Deputy Program Director for OMDRHO in 2017 and ultimately became OMDRHO Program Director in February 2022.